Personalized Medicine Coalition (PMC)Personalized Medicine Coalition - is a non-governmental, non-profit group established to foster the discussion, and to advance the understanding and adoption, of Personalized Medicine concepts and products for the ultimate benefit of patients who need them.

Sign up to receive the PMC newsletter
About PMC News & Events Programs Science & Public Policy Membership Communications Resources Contact Us
science & public policy
[ public policy ] [ science ] [ personalized medicine 101 ] [ related articles & presentations ]
[ pmc task forces ]

related articles & presentations

“Advocacy groups as research organizations: the PXE International example”
Nature
February 2007
webpage  View Article
*Subscription required to view article

“Is your medication right for you? The latest in personalized medicine”
Health Radio Network
January 28, 2007
webpage  Listen to segment

“Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients”
Molecular Psychiatry
January 2, 2007
webpage  View Article
*See "Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients."

“Remarks as delivered to the President's Council of Advisors on Science and Technology”
Alex M. Azar II, Deputy Secretary of Health and Human Services December 9, 2006
webpage  View Speech

“Genomic signatures to guide the use of chemotherapeutics”
Nature Medicine
November, 2006
webpage  View Article
*Subscription required to view article

“Right Drug, Right Patient, Right Now”
Duke Institute For Genome Sciences & Policy
October 27, 2006
webpage  View Article

"Researchers Draft Guidelines for Clinical Use of Pharmacogenomics"
The Journal of the American Medical Association
September 27, 2006
webpage  View Article
*Subscription required to view article

“Getting personal: Genetic testing and custom-tailored drug treatments promise a sea change in pharmacy practice”
 Drug Topics
 September 18, 2006
webpage  View Article

“A Genomic Strategy to Refine Prognosis in Early-Stage Non-Small-Cell Lung Cancer”
 New England Journal of Medicine
 August 10, 2006
webpage  View Article

“Personalized Medicine Will Not Destroy Blockbuster Model - Pfizer Exec”
 The Pink Sheet
 May 22, 2006
webpage  View Article
*Subscription required to view article

“A Crystal Ball Submerged in a Test Tube”
 Andrew Pollack
 The New York Times
 April 13, 2006
webpage  View Article

"Personalized Medicine To Be HHS Focus In Administration's Final Thousand Days,
Leavitt Says"
Andrew Kasper
Health News Daily
April 12, 2006
webpage  View Article
* Subscription required to view article

"GSK's Allan Roses Says PGx Is Not Only Here, It's Already Paying Off"
Bernadette Toner
GenomeWeb Daily News
April 6, 2006
webpage  View Article

"Pharmacogenomics and the Brave New World of Personalized Medicine"
Angelo De Palma, Ph.D.
Pharmaceutical Manufacturing
March 2006
webpage  View Article

"Personalized Medicine: The "Perfect Storm" for Improving Genetic Test Quality"
Research Policy Alert
February 20, 2006
webpage  View Article
Subscription required to view full article

"Wal-Mart, Google, and the Future of Medicine"
Bio-IT World
Dec 2005/Jan 2006
webpage  View Article

"New Genetic Tests Boost Impact of Drugs"
The Wall Street Journal
December 21, 2005
webpage  View Article
Subscription required to view full article

"PGx Round Table: Delivery to patients and acceptance"
Pharmacogenomics e-Symposium 2005
December 12, 2005
video  Listen to Webcast

"Personalized Medicine: Are We Really Ready for This Revolution?"
G. Steven Burrill, CEO, Burrill & Company
October 18, 2005
pdf  View Presentation

"Medicines Personalised to Patients Still Decades Away"
The UK Royal Society Report
September 21, 2005
webpage  View Article

"Proposal to Study Personalized Medicine"
President's Council of Advisors on Science and Technology (PCAST)
M. Kathleen Behrens
September 20, 2005
pdf  View Presentation

"Biomarkers Come of Age"
Suzanne Z. Mattingly, Bo E. H. Saxberg
Pharmaceutical Executive
September 1, 2005
webpage  View Article

"Personalized Medicine - How it Will Affect Your Healthcare"
Brian Munroe, President, Personalized Medicine Coalition
April 26, 2005
pdf  View Presentation

"Personalized Medicine: Transforming Drug Discovery and Development"
Ronenn Roubenoff, MD, MHS, FACP, FACR, Sr. Director, Molecular Medicine Millennium Pharmaceuticals, Cambridge, MA Adjunct
Professor of Nutrition & Medicine, Tufts University, Boston, MA
pdf  View Presentation

"The Power of Personalized Medicine: Changing Medicine and People's Lives"
Geoffrey S. Ginsburg, M.D., Ph.D.
Director, Center for Genomic Medicine
Duke University
pdf  View Presentation

"Personalized Medicine – How the Human Genome Era Will Usher in a
Healthcare Revolution"
Francis S. Collins, M.D., Ph.D., Director, National Human Genome Research Institute,
National Institutes of Health
February 10, 2005
pdf  View Presentation
pdf  View Video

"Quo Vadis Personalized Medicine?"
Gualberto Ruaño
Personalized Medicine Journal
December 2004
pdf  View Article

"A Coalition to Drive Personalized Medicine Forward"
J. Brian Munroe
Personalized Medicine Journal
December 2004
pdf  View Article

"Really Personal Medicine"
Suzanne Mattingly, Ph.D.
Techcomm
October 2004
pdf  View Article

"The Public Policy Issues of Personalized Medicine: Where Do We Go from Here?" (*)
J. Brian Munroe
Regulatory Affairs Focus
September 2004
pdf  View Article

"HER2 Testing - Fish : Coding & Payment - The Problem, The Fix, Lessons Learned"
Paul R. Landauer, Abbott Molecular Diagnostics
PMC Forum Webcast
September 23, 2004
pdf  View Presentation

"HERCEPTIN® (Trastuzumab) A Real World Example of Pharmacogenomics – Maximizing Patient Benefit"
Cheryl A. Madsen, RAC, Genentech, Inc.
PMC Forum Webcast
September 23, 2004
pdf  View Presentation

(*) Regulatory Affairs Professionals Society (RAPS) does not grant permission to download the article from the Web site and make reprints to distribute for any reason other than personal or noncommercial classroom use.

 
© 2008 Personalized Medicine Coalition, please see our Privacy and Usage policies.